Table of Contents Author Guidelines Submit a Manuscript
Malaria Research and Treatment
Volume 2015, Article ID 405962, 5 pages
http://dx.doi.org/10.1155/2015/405962
Research Article

A Pharmacokinetic Study of Antimalarial 3,5-Diaryl-2-aminopyridine Derivatives

1Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Observatory, Cape Town 7925, South Africa
2Department of Chemistry, University of Cape Town, Rondebosch, Cape Town 7700, South Africa

Received 5 January 2015; Revised 16 March 2015; Accepted 18 March 2015

Academic Editor: Neena Valecha

Copyright © 2015 Ntokozo Dambuza et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. A. Clark, L. M. Alleva, A. C. Mills, and W. B. Cowden, “Pathogenesis of malaria and clinically similar conditions,” Clinical Microbiology Reviews, vol. 17, no. 3, pp. 509–539, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Panichakul, J. Sattabongkot, K. Chotivanich, J. Sirichaisinthop, L. Cui, and R. Udomsangpetch, “Production of erythropoietic cells in vitro for continuous culture of Plasmodium vivax,” International Journal for Parasitology, vol. 37, no. 14, pp. 1551–1557, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. World Health Organization, World Malaria Report 2013, WHO, Geneva, Switzerland, 2013, http://apps.who.int/iris/bitstream/10665/144852/2/9789241564830_eng.pdf.
  4. C. P. Sanchez, A. Dave, W. D. Stein, and M. Lanzer, “Transporters as mediators of drug resistance in Plasmodium falciparum,” International Journal for Parasitology, vol. 40, no. 10, pp. 1109–1118, 2010. View at Publisher · View at Google Scholar
  5. D. Gonzalez Cabrera, F. Douelle, Y. Younis et al., “Structure-activity relationship studies of orally active antimalarial 3,5-substituted 2-aminopyridines,” Journal of Medicinal Chemistry, vol. 55, no. 24, pp. 11022–11030, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Younis, F. Douelle, T.-S. Feng et al., “3,5-diaryl-2-aminopyridines as a novel class of orally active antimalarials demonstrating single dose cure in mice and clinical candidate potential,” Journal of Medicinal Chemistry, vol. 55, no. 7, pp. 3479–3487, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Younis, F. Douelle, D. González Cabrera et al., “Structure-activity-relationship studies around the 2-amino group and pyridine core of antimalarial 3,5-diarylaminopyridines lead to a novel series of pyrazine analogues with oral in vivo activity,” Journal of Medicinal Chemistry, vol. 56, no. 21, pp. 8860–8871, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. J. C. Austin, D. du Toit, N. Fraser et al., Guidelines on Ethics for Medical Research: Use of Animals in Research and Training, Book 3, South African Medical Research Council, 2004.
  9. Wahajuddin, S. P. Singh, K. S. R. Raju, A. Nafis, S. K. Puri, and G. K. Jain, “Intravenous pharmacokinetics, oral bioavailability, dose proportionality and in situ permeability of anti-malarial lumefantrine in rats,” Malaria Journal, vol. 10, article 293, 2011. View at Publisher · View at Google Scholar
  10. C. A. Boswell, E. E. Mundo, S. Ulufatu et al., “Comparative physiology of mice and rats: radiometric measurement of vascular parameters in rodent tissues,” Molecular Pharmaceutics, vol. 11, no. 5, pp. 1591–1598, 2014. View at Publisher · View at Google Scholar · View at Scopus